Disclosure under regulation 30 of SEBI regulations, 2015 - Investor Presentation

HEXAGON NUTRITION LIMITED 'Nutritionally Yours... Ref: HNL/SEC/2026-27/20 Date: 14th August 2026 Na(cid:415)onal Stock Exchange of India Limited BSE Limited Lis(cid:415)ng & Compliance Department Lis(cid:415)ng Department Exchange Plaza, C-1, Block G, Floor 25, P J Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400001 Mumbai – 400051, Maharashtra, India. Maharashtra, India. SYMBOL: HEXAGON Scrip Code: 544785 Dear Sir/Madam, Ref: HEXAGON NUTRITION LIMITED - ISIN: INE0JUI01012 Subject: Disclosure Under Regulation 30 Of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) – Q1 FY27 - Result Presentation Pursuant to the provisions of Regulation 30 of the Listing Regulations read with Para A (15)(a) of Part A of Schedule III thereto, In continuation to our letter dated 10th August 2026 regarding intimation of Earnings Call of the Company scheduled on Friday, 14th August 2026 at 04:00 p.m. to discuss the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended on 30th June 2026, kindly find enclosed herewith Presentation for Q1FY27 Result of the Company. The above disclosure is also being made available on the website of the Company at www.hexagonnutrition.com This is for your information and records. Yours faithfully, For Hexagon Nutrition Limited Vedanti Vartak Company Secretary and Compliance Officer ICSI Membership No.: A41580 CIN:- L24110MH1993PLC072189 Nashlk Plant : Registered Office : Plot No. 92 & Plot No. 447, Unandanagar, Lakhamapur, 404 Global Chamber, Ada rsh Nagar, Link Road, Dlndorl, Naslk - 422 202, Maharashtra, lndla Andherl (W), Mumbai, Maharashtra - 400053, lndla Tel, No.: +91-22-62136710/711 Chennal Plant : Website : www.hexagonnutrltlon.com Plot No. B11, Phase - 1 MEPZ-SEZ, Tambaram, Emall ID: enqulry@hexagonnutrltlon.com Chennal - 600 045, Tamll Nadu, India Investor Presentation Q1 FY27 STRENGTH IMMUNITY ENERGY Disclaimer This presentation has been prepared by Hexagon Nutrition Limited, solely to provide information about the Company to its stakeholders. No representation or warranty,expressorimplied ismadeasto,andnoreliance shouldbeplacedon,thefairness,accuracy,completenessor correctnessof suchinformationoropinions containedherein.NoneoftheCompanynoranyofitsrespectiveaffiliates,advisersorrepresentatives,shallhaveanyliabilitywhatsoever(innegligenceorotherwise) foranylosshowsoeverarisingfromanyuseofthispresentationoritscontentsorotherwise arisinginconnectionwiththispresentation. The information contained in this presentation is only current as of itsdate. The Company may alter, modify or otherwise change in any manner the content of this presentation, without obligation to notify any person of such revision or changes. Certain statements made in this presentation may not be based on historical information or facts and may be "forward-looking statements", including those relating to the Company’s general business plans and strategy, its future financial condition and growth prospects, and future developments in its industry and its competitive and regulatory environment. Actual results may differ materially from these forward-looking statements due to number of factors, including future changes or developments in the Company’s business, its competitive environment, informationtechnologyandpolitical,economic,legalandsocialconditionsinIndia. PleasenotethatthispresentationisbasedonthepubliclyavailableinformationincludingbutnotlimitedtoCompany’swebsiteandAnnualReports. This communication is for general information purposes only, without regard to specific objectives, financial situations and needs of any particular person. Please notethatinvestmentsinsecuritiesaresubjecttorisksincludinglossofprincipalamount. Thispresentationdoesnotconstituteanofferorinvitationtopurchaseorsubscribeforanysharesinthecompanyandneitheranypartofitshallformthebasisofor berelieduponinconnectionwithanycontractorcommitmentwhatsoever. 01 COMPANY OVERVIEW 02 PRODUCT PORTFOLIO & BRANDS Snapshot, evolution, vision, and business Pentasure, Pediagold, Obesigoand model more TABLE OF 03 MANUFACTURING & R&D 04 INDUSTRY OVERVIEW CONTENTS Plants, capacity, certifications, and Market size, tailwinds, and competitive innovation landscape FINANCIAL PERFORMANCE GROWTH STRATEGY & OUTLOOK 05 06 Revenue, EBITDA, PAT, balance sheet Organic growth, new categories, global expansion MANAGEMENT & GOVERNANCE APPENDIX 07 08 Promoters, board, leadership team Financial statements, certifications, awards COMPANY OVERVIEW Indian Nutrition Market Industry trends RAPID GROWTH DRIVERS Rising health awareness, higher disposable incomes, and supportive government policies are propelling demand across dietary supplements, functional foods, and medical nutrition. DIVERSE CONSUMER BASE Nutritional needs vary regionally —North India favors protein and multivitamin products, while South India focuses on diabetes and hypertension supplements. MARKET OUTLOOK & CHALLENGES India ranks among the top global nutrition markets; however, affordability, misinformation, and regional gaps persist —requiring innovation, education, and accessibility initiatives. Younger Consumers Prioritise wellness, Older Consumers Managing chronic spending through trusted, medically conditions, spending through trusted, backed products. medically backed products. Company Snapshot One Company. Full Nutrition Spectrum Research-driven, pure-play nutrition company spanning the full value chain — from micronutrient premixes to therapeutic and clinical products — under one integrated platform. ₹1,043 Mn ₹118 Mn ₹81 Mn Founded 1993 · Mumbai, Maharashtra Q1 FY27 Revenue Q1 FY27 EBITDA Q1 FY27 PAT Employees 527+ permanent staff Margin: 11.3% Margin: 7.7% Mfg. Plants 4 (Nashik, Chennai, Thoothukudi, Uzbekistan) R&D Centres 2 (Nashik + Chennai) Countries 80+ export markets Distributors 358 domestic + 20 international Certifications FSSC 22000, ISO 9001, GMP, Halal Corporate Evolution — 30+ Years of Building India's Nutrition Leader Hong Kong & Founded ICAR UNICEF Nutrone ₹3,000+ Mn Uzbekistan Nashik plant · Approval received for Production approval for Incorporated wholly owned New brand launch · Annual revenue Micronutrient food testing the MNP incorporated Asia-Pacific & Everyday nutrition milestone crossed formulations laboratory central Asia 1993 2004 2013 2017 2018 2019 2020 2022 2023 2024 2025 2026 Chennai Plant DSIR R&D South Africa Amalgamation of NRPL Certificate of recognition 2nd manufacturing DSIR approval – WOS incorporated · - with HNL Certificate of B2C revenue facility · Export focus Chennai R&D Facility Africa expansion recognition being milestone part in Dun and crossed 100 cr& Bradstreet Global Listed on NSE & Database BSE -June 2026 and Merger of HNEPL Chennai with HNL Vision, Mission & Values VISION MISSION To improve human health and nutrition through To be a globally recognized, research-driven nutrition innovative, affordable, and high-quality products company —the partner of choice for individuals, across wellness, clinical nutrition, food fortification, healthcare professionals, FMCG leaders, and and humanitarian nutrition — delivered with humanitarian organizations seeking science-backed consistency and care. nutritional solutions. QUALITY WITHOUT INTEGRITY & CUSTOMER PARTNERSHIP COMPROMISE SCIENCE FIRST INNOVATION GOVERNANCE SOCIAL IMPACT Long-term relationships with FSSC 22000, GMP, ISO 9001, Every product grounded in 9 products in R&D pipeline. Listed entity. Independent UN-licensed MNP supplier. FMCG majors, hospitals, and Halal, Intertek/GAIN certified nutritional science and Active new category entry directors. Audit committee. Addressing malnutrition in UN agencies. 55% repeat across all plants. clinical evidence. DSIR- strategy. Continuous Professional management 80+ countries. Aligned with customers. approved R&D centres. formulation upgrades. team. SDG goals. Our Pu [Showing first 8,000 characters — download PDF for full document]